FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
· nbcnews.com · popularity 59/100 · 1 similar story today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at nbcnews.com →
Summary
GLP-1 drugs may increase the risk of NAION, a rare optic nerve condition that can lead to sudden vision loss and has no known treatment. The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness. The …
Found in: News, Health, NBC News Top. Rating basis: 1 other outlets; outlet tier 5; 3 feeds; listed 3 times; feed position 12.